Keywords: update, astrazeneca, do, safety, trial, iressa, said

Update: AstraZeneca to do safety trial of Iressa

Article | 17 February 2003

Print This

AstraZeneca has said it intends to conduct a 5,000-patient safety studyof its non-small cell lung cancer drug Iressa (gefitinib), in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in